ID27759A - Derivat-derivat benzoilguanidina dengan sifat-sifat yang menguntungkan, proses-proses pembuatannya dan penggunaannya dalam pembuatan komposisi-komposisi farmasi - Google Patents

Derivat-derivat benzoilguanidina dengan sifat-sifat yang menguntungkan, proses-proses pembuatannya dan penggunaannya dalam pembuatan komposisi-komposisi farmasi

Info

Publication number
ID27759A
ID27759A IDW20010663A ID20010663A ID27759A ID 27759 A ID27759 A ID 27759A ID W20010663 A IDW20010663 A ID W20010663A ID 20010663 A ID20010663 A ID 20010663A ID 27759 A ID27759 A ID 27759A
Authority
ID
Indonesia
Prior art keywords
making
benzoilguanidine
derivates
processes
profitable
Prior art date
Application number
IDW20010663A
Other languages
English (en)
Indonesian (id)
Inventor
Blech Stefan Matthias
Burger Erich
Eickmeier Christian
Roos Peter
Roos Tamara
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ID27759A publication Critical patent/ID27759A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
IDW20010663A 1998-09-22 1999-09-16 Derivat-derivat benzoilguanidina dengan sifat-sifat yang menguntungkan, proses-proses pembuatannya dan penggunaannya dalam pembuatan komposisi-komposisi farmasi ID27759A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843489A DE19843489B4 (de) 1998-09-22 1998-09-22 Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung

Publications (1)

Publication Number Publication Date
ID27759A true ID27759A (id) 2001-04-26

Family

ID=7881872

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010663A ID27759A (id) 1998-09-22 1999-09-16 Derivat-derivat benzoilguanidina dengan sifat-sifat yang menguntungkan, proses-proses pembuatannya dan penggunaannya dalam pembuatan komposisi-komposisi farmasi

Country Status (35)

Country Link
EP (1) EP1165534B1 (cs)
JP (1) JP3817425B2 (cs)
KR (1) KR100621821B1 (cs)
CN (1) CN1166654C (cs)
AR (1) AR023668A1 (cs)
AT (1) ATE288425T1 (cs)
AU (1) AU764819C (cs)
BG (1) BG64985B1 (cs)
BR (1) BR9913107A (cs)
CA (1) CA2345006C (cs)
CO (1) CO5150207A1 (cs)
CZ (1) CZ300158B6 (cs)
DE (2) DE19843489B4 (cs)
EA (1) EA004687B1 (cs)
EE (1) EE04749B1 (cs)
EG (1) EG23757A (cs)
ES (1) ES2237951T3 (cs)
HK (1) HK1043367B (cs)
HR (1) HRP20010194B1 (cs)
HU (1) HU228955B1 (cs)
ID (1) ID27759A (cs)
IL (1) IL141805A (cs)
MY (1) MY121362A (cs)
NO (1) NO317993B1 (cs)
NZ (1) NZ511167A (cs)
PE (1) PE20001085A1 (cs)
PL (1) PL195291B1 (cs)
PT (1) PT1165534E (cs)
RS (1) RS49971B (cs)
SA (1) SA99200474B1 (cs)
SK (1) SK285578B6 (cs)
TR (1) TR200100801T2 (cs)
TW (1) TWI221841B (cs)
WO (1) WO2000017176A2 (cs)
ZA (1) ZA200101212B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10106970A1 (de) * 2001-02-15 2002-08-29 Boehringer Ingelheim Pharma Neues Benzoylguanidinsalz
US6730678B2 (en) * 2001-02-15 2004-05-04 Boehringer Ingelheim Pharma Kg Benzoylguanidine salt and hydrates thereof
US6982256B2 (en) 2001-09-07 2006-01-03 Boehringer Ingelheim Pharma Kg Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
DE10144030A1 (de) * 2001-09-07 2003-03-27 Boehringer Ingelheim Pharma Verbesserung der lokalen Verträglichkeit bei intravenöser Verabreichung von 4-(4-(2-Pyrrolylcarbonyl-1-piperazinyl)-3-trifluormethyl-benzoylguanidin
FR2871157A1 (fr) * 2004-06-04 2005-12-09 Aventis Pharma Sa Produits biaryl aromatiques, compositions les contenant et utilisation
JP2011527677A (ja) * 2008-07-08 2011-11-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｎｈｅ−１阻害剤として有用なピロリジニル及びピペリジニル化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19601303A1 (de) * 1996-01-16 1997-07-17 Boehringer Ingelheim Kg Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln

Also Published As

Publication number Publication date
IL141805A (en) 2005-12-18
TWI221841B (en) 2004-10-11
AU6465999A (en) 2000-04-10
CN1166654C (zh) 2004-09-15
NO317993B1 (no) 2005-01-17
NZ511167A (en) 2003-12-19
SK3962001A3 (en) 2001-10-08
NO20011428D0 (no) 2001-03-21
DE59911568D1 (de) 2005-03-10
PT1165534E (pt) 2005-04-29
HRP20010194B1 (en) 2009-05-31
CZ20011047A3 (cs) 2001-08-15
CZ300158B6 (cs) 2009-02-25
NO20011428L (no) 2001-03-21
KR20010079884A (ko) 2001-08-22
IL141805A0 (en) 2002-03-10
PE20001085A1 (es) 2000-10-25
JP2002538077A (ja) 2002-11-12
AU764819B2 (en) 2003-08-28
WO2000017176A3 (de) 2001-10-11
AR023668A1 (es) 2002-09-04
BG105326A (bg) 2001-11-30
MY121362A (en) 2006-01-28
RS49971B (sr) 2008-09-29
HRP20010194A2 (en) 2002-04-30
WO2000017176A2 (de) 2000-03-30
SA99200474B1 (ar) 2006-06-10
EE04749B1 (et) 2006-12-15
KR100621821B1 (ko) 2006-09-13
EA200100317A1 (ru) 2001-10-22
JP3817425B2 (ja) 2006-09-06
HK1043367B (zh) 2005-02-25
EP1165534B1 (de) 2005-02-02
ATE288425T1 (de) 2005-02-15
DE19843489B4 (de) 2006-12-21
EP1165534A2 (de) 2002-01-02
BR9913107A (pt) 2002-06-11
CN1342153A (zh) 2002-03-27
SK285578B6 (sk) 2007-04-05
PL195291B1 (pl) 2007-08-31
CA2345006A1 (en) 2000-03-30
CA2345006C (en) 2007-11-13
PL347234A1 (en) 2002-03-25
EG23757A (en) 2007-08-08
HUP0200225A3 (en) 2002-12-28
ES2237951T3 (es) 2005-08-01
TR200100801T2 (tr) 2002-04-22
AU764819C (en) 2004-12-16
BG64985B1 (bg) 2006-11-30
HU228955B1 (en) 2013-07-29
EE200100178A (et) 2002-10-15
YU21501A (sh) 2004-03-12
HK1043367A1 (en) 2002-09-13
HUP0200225A2 (en) 2002-06-29
CO5150207A1 (es) 2002-04-29
ZA200101212B (en) 2002-10-04
EA004687B1 (ru) 2004-06-24
DE19843489A1 (de) 2000-03-23

Similar Documents

Publication Publication Date Title
ID25528A (id) Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya
IL176317A0 (en) Compositions containing chemically modified small molecules and methods utilizing the same
IL174635A0 (en) Fibrosis-inducing agents, compositions containing the same and intravascular devices containing the same
AU2003271498A8 (en) Coolant solutions and compositions comprising the sameitle
GC0000046A (en) Compositions for use in well construction, repair and/or abandonment.
IL164021A0 (en) Antibodies and anti-pharmaceutical compositions containing the same
NO20011191L (no) Vedlikeholdsfrigivelses ranolazin i formuleringen
BR9915457B1 (pt) composições de moldagem, uso e artigo.
EP1617807A4 (en) SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
ID29236A (id) Benzopiran-benzopiran dan benzoksepin-benzoksepin, komposisi-komposisi famaseutikal yang mengandungnya, dan proses penyiapannya
HUP0401638A3 (en) Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same
HUP0500639A3 (en) Laundry additive composition, preparation and use thereof and detergent composition containing the same
EP1521791A4 (en) NORBORNENE ESTER ADDITION POLYMER AND PROCESS FOR PREPARING THE SAME
GB0026054D0 (en) Films,compositions and processes
IL204324A0 (en) Compositions useful as multisignal labeling reagents and processes utilizing the same
NO20010873L (no) Mikropartikkel-blanding
AU2003241742A8 (en) Rubber composition and tire obtained from the same
NO20021376D0 (no) Sikkerhetsventil nede i brönnen
TWI319762B (en) 1,7,8-trifluoro-2-naphthol and manufacturing methods for liquid crystal compositions containing the same
SG98483A1 (en) Heat-absorbing polymer composition
IS7140A (is) Endurbætur við eða í sambandi við hjúpun
AU2003218359A1 (en) Polymer composition and dosage forms comprising the same
IT1286525B1 (it) Agenti anti-incrostazione,composizioni che li contengono e loro impiego nei processi di polimerizzazione
ID27759A (id) Derivat-derivat benzoilguanidina dengan sifat-sifat yang menguntungkan, proses-proses pembuatannya dan penggunaannya dalam pembuatan komposisi-komposisi farmasi
IT1313700B1 (it) Composizioni anti-incrostazione e loro impiego nei processi dipolimerizzazione.